McKesson Corporation

MCK

New York Stock Exchange. Currency in USD

375.54 +2.90 ( +0.78% )

Real time prices: December 19

Market Cap.
53.25B
Beta (5Y monthly)
0.63
Price/Earnings
15.99
EPS (TTM)
23.87
Forward Dividend
2.16 (0.58%)
Ex-Dividend Date
Dec 01, 2022
Volume
1.48M
1y Target Est.
414.79
Day's Range
371.80
-
380.94
52 Week's Range
252.61
-
401.78

Historical Summary

Performance
EPS growth
Share Buybacks

About McKesson Corporation

Sector
Healthcare
Industry
Medical Distribution
Website
https://www.mckesson.com
Exchange
New York Stock Exchange (XNYS)
Shares Outstanding
152.68M
Employees
58000
Address
6555 State Highway 161, Irving, TX, United States, 75039
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The International segment offers distribution and services to wholesale, institutional, and retail customers in 13 European countries and Canada. The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers. The RxTS segment serves biopharma and life sciences partners and patients to address medication challenges for patients throughout their journeys; connects pharmacies, providers, payers, and biopharma companies to deliver innovative access and adherence solutions; and provides third-party logistics and wholesale distribution support solutions. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.

Latest news

All You Need to Know About McKesson (MCK) Rating Upgrade to Buy
All You Need to Know About McKesson (MCK) Rating Upgrade to Buy

McKesson (MCK) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about...
By Zacks Investment Research - 6 weeks ago

HCA Healthcare's (HCA) ESR Program Aids Post-Surgery Recovery
HCA Healthcare's (HCA) ESR Program Aids Post-Surgery Recovery

HCA Healthcare's (HCA) ESR program remains on track to attract more patients to choose HCA's...
By Zacks Investment Research - 6 weeks ago

Are Medical Stocks Lagging  Immunovant (IMVT) This Year?
Are Medical Stocks Lagging Immunovant (IMVT) This Year?

Here is how Immunovant, Inc. (IMVT) and McKesson (MCK) have performed compared to their sector...
By Zacks Investment Research - 6 weeks ago

7 New Stocks Warren Buffett Bought in 2022
7 New Stocks Warren Buffett Bought in 2022

Buffett's company Berkshire Hathaway didn't sit around this year.
By The Motley Fool - 6 weeks ago

2023 Is Almost Here. Should You Keep Investing Right Now?
2023 Is Almost Here. Should You Keep Investing Right Now?

Before making a move, take a long-term view.
By The Motley Fool - 6 weeks ago

Have $1,000? 2 Warren Buffett Stocks to Buy
Have $1,000? 2 Warren Buffett Stocks to Buy

End the year on a Buffett-inspired note.
By The Motley Fool - 6 weeks ago

McKesson (MCK) Outpaces Stock Market Gains: What You Should Know
McKesson (MCK) Outpaces Stock Market Gains: What You Should Know

McKesson (MCK) closed the most recent trading day at $377.75, moving +1.71% from the previous...
By Zacks Investment Research - 6 weeks ago

LabCorp (LH) Gains on Innovation Amid Currency Headwinds
LabCorp (LH) Gains on Innovation Amid Currency Headwinds

LabCorp (LH) enters into a collaboration with Becton, Dickinson and Company to help match patients...
By Zacks Investment Research - 6 weeks ago